Opioid use disorders as an emerging disability

被引:1
|
作者
Lusk, Stephanie L. [1 ]
Stipp, Addyson [1 ]
机构
[1] Univ Arkansas, Fayetteville, AR 72701 USA
关键词
Opioid use disorder; rehabilitation counseling; pain medication;
D O I
10.3233/JVR-180943
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
BACKGROUND: The rates of opioid use disorders have notably increased over the years. Initially opioid pain medications were reserved for individuals who experienced chronic pain associated with cancer (malignant) or pain post-surgery, but because of their effectiveness in alleviating pain, the widespread use of these medications resulted. In 2014 alone, American pharmacies distributed 245 million opioid prescriptions, and consequently, the United States now accounts for nearly 100% of the world's hydrocodone and 81% of the world's oxycodone use. OBJECTIVE: In this article, the authors explore how opioid use disorders develop and those at most risk of developing opioid use disorders by discussing the unique pharmacology of opioids and how they increase the propensity of addiction. Terms of treatment - such as types of treatment, recovery-oriented services, and alternative or complementary forms of treatment - are discussed as well as considerations for addressing some of the challenges of working with these individuals. CONCLUSION: Implications for vocational rehabilitation professionals, such as suggestions for screening, making referrals to specialists for those with chronic pain conditions, and the need for continuing education are included.
引用
收藏
页码:345 / 358
页数:14
相关论文
共 50 条
  • [22] Postoperative opioid misuse in patients with opioid use disorders maintained on opioid agonist treatment
    Namiranian, Khodadad
    Siglin, Jonathan
    Sorkin, John David
    Norris, Edward J.
    Aghevli, Minu
    Covington, Edward C.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 109 : 8 - 13
  • [23] Maintenance pharmacologic therapies for opioid use disorders: beyond opioid agonists
    Vasiliu, Octavian
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2019, 122 (01) : 52 - 70
  • [24] Tapering off Medications for Opioid Use Disorders
    Jason, Leonard A.
    Nieder, Alexa
    Sikora, Alexander
    Garrity, Elizabeth
    Bobak, Ted
    ALCOHOLISM TREATMENT QUARTERLY, 2025,
  • [25] Update on Barriers to Pharmacotherapy for Opioid Use Disorders
    Anjalee Sharma
    Sharon M. Kelly
    Shannon Gwin Mitchell
    Jan Gryczynski
    Kevin E. O’Grady
    Robert P. Schwartz
    Current Psychiatry Reports, 2017, 19
  • [26] Neuroimmune mechanisms of psychostimulant and opioid use disorders
    Hofford, Rebecca S.
    Russo, Scott J.
    Kiraly, Drew D.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 50 (03) : 2562 - 2573
  • [27] BINGE DRINKING CONTRIBUTING TO OPIOID USE DISORDERS
    Huang, W.
    Han, H.
    Du, W.
    Thangavel, S.
    Chang, S. L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 36A - 36A
  • [28] Estimating State Transitions for Opioid Use Disorders
    Krebs, Emanuel
    Min, Jeong E.
    Evans, Elizabeth
    Li, Libo
    Liu, Lei
    Huang, David
    Urada, Darren
    Kerr, Thomas
    Hser, Yih-Ing
    Nosyk, Bohdan
    MEDICAL DECISION MAKING, 2017, 37 (05) : 483 - 497
  • [29] Injectable pharmacotherapy for opioid use disorders (IPOD)
    Farabee, David
    Hillhouse, Maureen
    Condon, Timothy
    McCrady, Barbara
    McCollister, Kathryn
    Ling, Walter
    CONTEMPORARY CLINICAL TRIALS, 2016, 49 : 70 - 77
  • [30] Pain Management for Patients With Opioid Use Disorders
    Lyden, Abbie
    Neu, Rachel
    ORTHOPAEDIC NURSING, 2025, 44 (01) : 42 - 51